Algo version: 0.98b
Biogen Inc is listed at the XETRA Exchange
Biogen Inc [IDP.DE]
XETRA Sector: Biotechnology Industry:Drug Manufacturers—General

Is Biogen Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Biogen Inc 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €205.90, you would have made a loss of €-26.10 per share or -12.68%

No, the average daily trading liquidity for Biogen Inc is €377 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Biogen Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.24, the company's ability to pay off the debt is normal. Biogen Inc has a good net profit margin of 12.07% and should have high tolerances against inflation.

We have calculated the inflation risk for Biogen Inc to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.